Chinese patent medicine is an important part of pharmaceutical products in China. In order to speed up the establishment of an effective evaluation index system for the variety selection and clinical application of Chinese patent medicine in line with the characteristics of traditional Chinese medicine ，so as to scientifically select drugs and carry out the clinical application evaluation of Chinese patent medicine in a standardized and reasonable manner ，Jiangsu Society of Traditional Chinese Medicine and Traditional Chinese Medicine Special Committee of Nanjing Pharmaceutical Society have organized the formulation of this expert consensus. Consensus experts have used literature research method ，brainstorming method ，analytic hierarchy process ， Delphi method ，etc. to build an evaluation index system for the selection and clinical application of Chinese patent medicine ， including 24 secondary indicators and 102 tertiary indicators ，from the seven dimensions of safety ，effectiveness，economy， innovation，suitability，accessibility and clinical application （primary indicators ）. It is expected to provide decision-making basis for the variety selection and evaluation of Chinese patent medicine by the pharmaceutical management and pharmacotherapeutics committee（group）of medical institutions ，promote medical institutions at all levels to continuously optimize the medication catalogue and medication structure ，and accelerate the formation of the “1 + X ”（“1”for the essential medicine ，“X”for non-essential medicine ） medication model dominated by essential drugs ，promote medical institutions to use Chinese patent medicines scientifically ，reasonably and safely ，so as to improve the quality of pharmaceutical care ，control the irrational drug use and cost ，and better meet the drug use needs of the people.